换一批
换一批Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
作者：
关键词
2′,7′-dichlorohydrofluorescein diacetate3-morpholinosydnonimine4’,6-Diamidino-2-PhenylindoleAEABDMBSACBCFACNTFComplete Freunds AdjuvantDAPIDCFDMEMDulbecco’s modified Eagle’s mediumEAEIHCMOGMSNTPBSPDGFROSSIN-1T cellsTBSTTHCTNF-αTris-buffered saline and Tween 20arachidonoyl ethanolamide (Anandamide)bFGFbasal chemically-defined mediumbasic fibroblast growth factorbovine serum albumincannabinoidciliary neurotrophic factorexperimental autoimmune encephalomyelitisimmunohistochemistrymicrogliamultiple sclerosismyelin oligodendrocyte glycoproteinmyelinationnitrotyrosineoligodendrocytephosphate-buffered solutionplatelet-derived growth factorreactive oxygen speciestetrahydrocannabinoltumor necrosis factor-α
主题词
酰胺类(Amides);动物(Animals);大麻酚类(Cannabinoids);细胞, 培养的(Cells, Cultured);脑脊髓炎, 自身免疫性, 实验性(Encephalomyelitis, Autoimmune, Experimental);女(雌)性(Female);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);大鼠(Rats);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);受体, 大麻酚, CB1(Receptor, Cannabinoid, CB1);雷琐辛类(Resorcinols)
DOI
10.1016/j.neuroscience.2013.09.005
PMID
24036373
发布时间
2013-11-15
- 浏览36
Neuroscience
427-42页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
